Jianwei Xu

Jianwei Xu is an experienced professional in the biotech and healthcare investment sectors, serving as Chief Business Officer at Molecular Targeting Technology, Inc. since April 2018, where the focus is on innovative radiopharmaceutical agents for cancer therapies and diagnostics. Jianwei has also been a Partner at Zox Capital since August 2012 and has been the Managing Director at Cambridge Solutions LLC since September 2010, providing consulting services in the pharmaceutical and biotech industries. Previous roles include Project Manager at Competitive Intelligence Service Inc., Associate at McKinsey & Company, and Postdoctoral Fellow at both Children's Hospital of Philadelphia and the University of Pennsylvania. Jianwei possesses extensive expertise in psychiatric and neurological diseases, project management, and business development, supported by a BS in Chemistry from the University of Science and Technology of China and a PhD in Neuroscience from the University at Buffalo.